For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine a fast-moving trend involving the ...